Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

Markus Stana; Brane Grambozov; Christoph Gaisberger; Josef Karner; Elvis Ruznic; Johannes Berchtold; Barbara Zellinger; Raphaela Moosbrugger; Michael Studnicka; Gerd Fastner; Felix Sedlmayer; Franz Zehentmayr

doi:10.3390/diagnostics12051027

Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

Markus Stana (First author), Brane Grambozov (Co-author), Christoph Gaisberger (Co-author), Josef Karner (Co-author), Elvis Ruznic (Co-author), Johannes Berchtold (Co-author), Barbara Zellinger (Co-author), Raphaela Moosbrugger (Co-author), Michael Studnicka (Co-author), Gerd Fastner (Co-author), Felix Sedlmayer (Co-author), Franz Zehentmayr^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

5 Citations (Web of Science)

Original language	English
Journal	DIAGNOSTICS
Volume	12
Issue number	5
DOIs	https://doi.org/10.3390/diagnostics12051027
Publication status	Published - 19 Apr 2022

Keywords

COMBINED PULMONARY-FIBROSIS
DENSITY CHANGES
RADIOTHERAPY
EMPHYSEMA
PNEUMONITIS
VALIDATION
THERAPY
IMPACT

Access to Document

10.3390/diagnostics12051027

Cite this

Stana, M., Grambozov, B., Gaisberger, C., Karner, J., Ruznic, E., Berchtold, J., Zellinger, B., Moosbrugger, R., Studnicka, M., Fastner, G., Sedlmayer, F., & Zehentmayr, F. (2022). Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. DIAGNOSTICS, 12(5). https://doi.org/10.3390/diagnostics12051027

@article{35c694a329e0419ca4acf408bd2bbdf8,

title = "Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III",

keywords = "COMBINED PULMONARY-FIBROSIS, DENSITY CHANGES, RADIOTHERAPY, EMPHYSEMA, PNEUMONITIS, VALIDATION, THERAPY, IMPACT",

author = "Markus Stana and Brane Grambozov and Christoph Gaisberger and Josef Karner and Elvis Ruznic and Johannes Berchtold and Barbara Zellinger and Raphaela Moosbrugger and Michael Studnicka and Gerd Fastner and Felix Sedlmayer and Franz Zehentmayr",

note = "Stana, Grambozov, Gaisberger, Karner, Ruznic, Fastner, Sedlmayer, Zehentmayr: Department of Radiation Oncology, Paracelsus Medical University, SALK, 5020 Salzburg, Austria; Zellinger: Institute of Pathology, Paracelsus Medical University, SALK, 5020 Salzburg, Austria; Studnicka: Department of Pneumology, Paracelsus Medical University, SALK, 5020 Salzburg, Austria ",

year = "2022",

month = apr,

day = "19",

doi = "10.3390/diagnostics12051027",

language = "English",

volume = "12",

journal = "DIAGNOSTICS",

issn = "2075-4418",

publisher = "MDPI",

number = "5",

}

Stana, M , Grambozov, B , Gaisberger, C , Karner, J , Ruznic, E, Berchtold, J, Zellinger, B, Moosbrugger, R, Studnicka, M , Fastner, G, Sedlmayer, F & Zehentmayr, F 2022, 'Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III', DIAGNOSTICS, vol. 12, no. 5. https://doi.org/10.3390/diagnostics12051027

Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. / Stana, Markus (First author); Grambozov, Brane (Co-author); Gaisberger, Christoph (Co-author) et al.
In: DIAGNOSTICS, Vol. 12, No. 5, 19.04.2022.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

AU - Stana, Markus

AU - Grambozov, Brane

AU - Gaisberger, Christoph

AU - Karner, Josef

AU - Ruznic, Elvis

AU - Berchtold, Johannes

AU - Zellinger, Barbara

AU - Moosbrugger, Raphaela

AU - Studnicka, Michael

AU - Fastner, Gerd

AU - Sedlmayer, Felix

AU - Zehentmayr, Franz

N1 - Stana, Grambozov, Gaisberger, Karner, Ruznic, Fastner, Sedlmayer, Zehentmayr: Department of Radiation Oncology, Paracelsus Medical University, SALK, 5020 Salzburg, Austria; Zellinger: Institute of Pathology, Paracelsus Medical University, SALK, 5020 Salzburg, Austria; Studnicka: Department of Pneumology, Paracelsus Medical University, SALK, 5020 Salzburg, Austria

PY - 2022/4/19

Y1 - 2022/4/19

KW - COMBINED PULMONARY-FIBROSIS

KW - DENSITY CHANGES

KW - RADIOTHERAPY

KW - EMPHYSEMA

KW - PNEUMONITIS

KW - VALIDATION

KW - THERAPY

KW - IMPACT

U2 - 10.3390/diagnostics12051027

DO - 10.3390/diagnostics12051027

M3 - Original Article

C2 - 35626183

SN - 2075-4418

VL - 12

JO - DIAGNOSTICS

JF - DIAGNOSTICS

IS - 5

ER -